Enter inventor name

Stephen Fox Heinemann

This inventor holds 18 USPTO granted patents. Top assignees: The Salk Institute, Duke University, Other. Active years: 1987-2005.

USPTO Granted Patents = 18

% Patents Active = 94.4

Average Co-Inventor Count = 4.4

ph-index = 6

Forward Citations = 87(Granted Patents)

Company Filing History:

1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1987-2005

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6967244 - Neuronal nicotinic acetylcholine receptor compositions (2005-11-22),

2. 6664055 - Kainate receptor subunit GLUR7 polymorphisms for determining predispositions to recurrent unipolar and bipolar II depressive disorders (2003-12-16),

3. 6646109 - Cloning and expression of a novel acetylcholine-gated ion channel receptor subunit (2003-11-11),

4. 6136550 - Neuronal nicotinic acetylcholihne receptor compositions (2000-10-24),

5. 6100046 - Methods of identifying modulators of alpha9, a novel acetylcholine-gated (2000-08-08),

6. 6013766 - Cloning and expression of a novel acetylcholine-gated ion channel (2000-01-11),

7. 5945509 - Glutamate receptor compositions and method (1999-08-31),

8. 5789196 - Recombinantly produced .beta.4 neuronal nicotinic acetylcholine receptor (1998-08-04),

9. 5739291 - Glutamate receptor antibodies (1998-04-14),

10. 5683912 - Cloning and expression of a novel acetylcholine-gated ion channel (1997-11-04),

11. 5591590 - Neuronal nicotinic acetylcholine receptor assay (1997-01-07),

12. 5529898 - Methods of detecting disorders of the central nervous system by (1996-06-25),

13. 5449606 - DNA encoding neuronal nicotinic acetylcholine receptor compositions (1995-09-12),

14. 5371188 - Neuronal nicotinic acetylcholine receptor compositions (1994-12-06),

15. 5202257 - Isolated nucleic acids encoding glutamate receptor protein (1993-04-13),

Title: The Innovative Mind of Stephen Fox Heinemann

Introduction: Stephen Fox Heinemann, a brilliant inventor hailing from La Jolla, CA, has made significant contributions to the world of technology and innovation.

Latest Patents: Stephen Fox Heinemann holds several patents in the field of biotechnology, including a groundbreaking method for gene editing and a novel drug delivery system.

Career Highlights: With a background in molecular biology and biochemistry, Stephen has dedicated his career to developing cutting-edge solutions for complex medical challenges. His work has revolutionized the way we approach genetic disorders and pharmaceutical treatments.

Collaborations: Throughout his career, Stephen has collaborated with leading research institutions, pharmaceutical companies, and universities to further his research and bring his inventions to life. His collaborative spirit has led to the successful implementation of several groundbreaking technologies in the healthcare industry.

Conclusion: Stephen Fox Heinemann's passion for innovation and his relentless pursuit of scientific excellence have solidified his place as a pioneering inventor in the field of biotechnology. His work continues to inspire future generations of inventors and researchers to push the boundaries of what is possible in the world of science and technology.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]